A Phase III Study of Regional Radiation Therapy in Early Breast Cancer

Radiotherapy to the breast reduces the risk of cancer coming back for women with early breast cancer. This international study will determine if treating a larger area with radiotherapy can further improve the results.

Primary Sponsor

NCIC CTG

Collaborating Groups

Trans Tasman Radiation Oncology Group (TROG)

Final Accrual

180

Trial Chairperson

International: Prof Timothy J. Whelan
TROG: A/Prof Boon Chua

Trial Contact

ymurray@ctg.queensu.ca

Clinical Trial Registration

Related Post

4 June, 2026

Report showcases a year of impactful research, collaboration and consumer engagement

LATEST NEWS: 4 June 2025 TROG’s latest Annual Research

ESTRO26 presentation
20 May, 2026

TROG trials in the spotlight at ESTRO26 international conference

LATEST NEWS: 20 MAY A number of TROG trials